Skip to main content
. 2021 Mar 25;35(4):e23733. doi: 10.1002/jcla.23733

TABLE 2.

Blood routine and CRP levels of the subjects

Normal rang AECOPD SCOPD Healthy controls P1 P2 P3
RBC (10 ~ 12/L)

3.50–5.50 (M)

3.8–5.10 (F)

4.69 ± 0.71 (M)

4.41 ± 0.58 (F)

4.58 ± 0.52 (M)

4.64 ± 0.51 (F)

4.82 ± 0.57 (M)

4.25 ± 0.27 (F)

0.122 (M)

0.214 (F)

0.462 (M)

0.101 (F)

0.031 (M)

0.033 (F)

Hb (g/L)

130–175 (M)

115–150 (F)

140.66 ± 19.38 (M)

126.92 ± 14.37 (F)

142.26 ± 15.85 (M)

131.00 ± 12.94 (F)

148.07 ± 10.10 (M)

130.05 ± 7.79 (F)

0.000 (M)

0.233 (F)

0.640 (M)

0.437 (F)

0.020 (M)

0.882 (F)

PLT (10 ~ 9/L) 125–350 198.93 ± 64.02 181.75 ± 56.19 199.36 ± 48.05 0.583 0.122 0.066
MPV (fL) 9.4–12.5 10.40 (9.30 11.40) 10.40 (9.50–11.50) 11.20 (10.20 12.20) 0.000 0.668 0.023
WBC (10 ~ 9/L) 3.50–9.50 8.59 ± 5.86 6.42 ± 1.40 6.18 ± 1.36 0.000 0.003 0.815
N (%) 40–75 73.78 ± 12.15 58.68 ± 10.56 58.35 ± 7.63 0.000 0.000 0.084
CRP (mg/L) 0–10.0 21.20 (7.33 78.50) 1.80 (1.40 2.70) 0.000

Data shown as mean ± SD, median (or interquartile range), P1 represents the difference between AECOPD and the controls, P2 represents AECOPD and SCOPD, P3 represents SCOPD and the controls.

Abbreviations: AECOPD, acute exacerbation of chronic obstructive pulmonary disease; CRP, C‐reactive protein; Hb, hemoglobin; MPV, mean platelet volume; N%, Percentage of neutrophils; PLT, platelet; RBC, red blood cell; SCOPD, stable Chronic obstructive pulmonary disease; WBC, white blood cell.